Related Experiment Video
Updated: Apr 30, 2026

05:22
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
Published on: November 4, 2025
1.1K
A DNA microarray-based assay to detect dual infection with two dengue virus serotypes
Alvaro Díaz-Badillo1, María de Lourdes Muñoz2, Gerardo Perez-Ramirez3
1Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Mexico D.F., 07360, Mexico. alvaro@cinvestav.mx.
Sensors (Basel, Switzerland)
|April 30, 2014
Summary
A new DNA microarray assay accurately detects dengue virus (DENV) serotypes, including dual infections. This sensitive method overcomes limitations of other techniques, improving dengue diagnosis.
Area of Science:
- Molecular Virology
- Diagnostic Technologies
- Infectious Diseases
Background:
- Dengue virus (DENV) poses a significant global health threat, with four distinct serotypes.
- Accurate serotype identification is crucial for disease management and epidemiological surveillance.
- Existing diagnostic methods may struggle to detect multiple DENV serotypes in a single sample.
Purpose of the Study:
- To describe and evaluate a novel microarray-based method for DENV serotype screening.
- To assess the specificity and sensitivity of the DNA microarray assay for detecting single and dual DENV infections.
- To provide a reliable tool for discriminating between the four DENV serotypes.
Main Methods:
- Development of a DNA microarray assay with single-stranded DNA targets covalently attached to glass slides.
- Hybridization of specific, labeled probes to detect DENV serotypes.
- Validation of the microarray assay using DENV isolates and clinical dengue samples.
Main Results:
- The DNA microarray assay demonstrated high specificity and sensitivity in detecting DENV serotypes.
- The method successfully identified both single-serotype and dual-serotype DENV infections.
- No non-specific signals were detected, confirming the accuracy of probe hybridization.
Conclusions:
- The developed microarray-based method is a robust tool for accurate DENV serotype identification.
- This technology effectively distinguishes between the four DENV serotypes and can detect mixed infections.
- The assay offers an improvement over existing methods that may underestimate multiple serotype infections.

